Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice

Behavioural Brain Research

Volumn 205, Issue 2, 2009, Pages 511-517

  Brüning, César Augusto ^a   Prigol, Marina ^a   Roehrs, Juliano A ^a   Nogueira, Cristina Wayne ^a   Zeni, Gilson ^a  

^a Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios   (Brazil)

Author keywords

Anxiolytic like; Elevated plus maze; Light dark box; m Trifluoromethyl diphenyl diselenide; Selenium; Serotonergic system

Indexed keywords

3 TRIFLUOROMETHYLDIPHENYL DISELENIDE; AMINE OXIDASE (FLAVIN CONTAINING); N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ONDANSETRON; ORGANOSELENIUM DERIVATIVE; RITANSERIN; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; LIGHT DARK CYCLE; LOCOMOTION; MAZE TEST; MITOCHONDRION; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROTONINERGIC SYSTEM; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIGHTING; LOCOMOTION; MAZE LEARNING; MICE; MONOAMINE OXIDASE; NEUROPSYCHOLOGICAL TESTS; ONDANSETRON; ORGANOSILICON COMPOUNDS; PIPERAZINES; PYRIDINES; RANDOM ALLOCATION; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN ANTAGONISTS;

EID: 70349771757     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.08.010     Document Type: Article

References (50)

1. Argyropoulos S.V., Sandford J.J., and Nutt D.J. The psychobiology of anxiolytic drug. Part 2: pharmacological treatments of anxiety. Pharmacol Ther 3 (2000) 213-227
2. Artaiz I., Romero G., Zazpe A., Monge A., Caldero J.M., Roca J., Lasheras B., and Del Rio J. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models. Psychopharmacology 117 (1995) 137-148
3. Benton D. Selenium intake, mood and other aspects of psychological functioning. Nutr Neurosci 5 (2001) 363-374
4. Benton D., and Cook R. The impact of selenium supplementation on mood. Biol Psychiatry 29 (1991) 1092-1098
5. Borsini F., Brambilla A., Cesana R., and Donetti A. The effect of DAU 6215, a novel 5-HT3 antagonist, in animal models of anxiety. Pharmacol Res 27 (1993) 151-164
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 72 (1976) 248-254
7. Blier P., and de Montigny C. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1 (1987) 470-480
8. Costall B., Jones B.J., Kelly M.E., Naylor R.J., and Tomkins D.M. Exploration of mice in a black and white box: validation as a model of anxiety. Pharmacol Biochem Behav 32 (1989) 777-785
9. Clénet F., Bouyon E., Hascoet M., and Bourin M. Light/dark cycle manipulation influences mice behavior in the elevated plus maze. Behav Brain Res 166 (2006) 140-149
10. Crawley J.N., and Goodwin F.K. Preliminary report of a simple animal behavior for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13 (1980) 167-170
11. Eguchi J., Inomata Y., and Saito K.I. The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism. Pharmacol Biochem Behav 68 (2001) 677-683
12. File S.E., and Johnston A.L. Lack of effects of 5-HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psychopharmacology 99 (1989) 248-251
13. Ghisleni G., Kazlauckas V., Both F.L., Pagnussat N., Mioranzza S., Rocha J.B.T., Souza D.O., and Porciúncula L.O. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: Putative roles of GABAA and 5HT receptors. Prog Neuro-psychoph 32 (2008) 1508-1515
14. Gomes P.B., Noronha E.C., Melo C.T.V., Bezerra J.N.S., Neto M.A., Lino C.S., Vasconcelos S.M.M., Viana G.S.B., and Sousa F.C.F. Central effects of isolated fractions from the root of Petiveria alliacea L. (tipi) in mice. J Ethnopharmacol 120 (2008) 209-214
15. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71 (2002) 533-554
16. Kessler R., McGonagle K., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51 1 (1994) 8-19
17. Kilfoil T., Michel A., Montgomery D., and Whiting R.L. Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice. Neuropharmacology 28 (1989) 901-905
18. Krajl M. A rapid microfluorimetric determination of monoamine oxidase. Biochem Pharmacol 14 (1965) 1683-1685
19. Luchese C., Pinton S., and Nogueira C.W. Brain and lungs of rats are differently affected by cigarette smoke exposure: Antioxidant effect of an organoselenium compound. Pharmacol Res 59 (2009) 194-201
20. Masse F., Petit-Demouliere B., Dubois I., Hascöet M., and Bourin M. Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test. Behav Brain Res 188 (2008) 291-297
21. Machado M.S., Rosa R.M., Dantas A.S., Reolon G.K., Appelt H.R., Braga A.L., Henriques J.A.P., and Roesler R. An organic selenium compound attenuates apomorphine-induced stereotypy in mice. Neurosci Lett 410 (2006) 198-202
22. Machado M.S., Villela I.V., Moura D.J., Rosa R.M., Salvador M., Lopes N.P., Braga A.L., Roesler R., Saffia J., and Henriques J.A.P. 3,3-Ditrifluoromethyldiphenyl diselenide: A new organoselenium compound with interesting antigenotoxic and antimutagenic activities. Mutat Res 673 (2009) 133-140
23. Matsumoto T., Furuta T., Nimura Y., and Suzuki O. 3-(p-Hydroxyphenyl)propionic acid as a new fluorogenic reagent for amine oxidase assays. Anal Biochem 138 (1984) 133-136
24. Nogueira C.W., Meotti F.C., Curte E., Pilissão C., Zeni G., and Rocha J.B.T. Investigations into the potential neurotoxicity induced by diselenides in mice and rats. Toxicology 183 (2003) 29-37
25. Nogueira C.W., Zeni G., and Rocha J.B.T. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 104 (2004) 255-285
26. Nolen W.A., Hoencamp E., Bouvy P.F., and Haffmans P.M. Reversible monoamine oxidase-A inhibitors in resistant major depression. Clin Neuropharmacol 16 Suppl 2 (1993) S69-76
27. Olivier B., Van Wijngaarden I., and Soudijn W. 5-HT3 receptor antagonists and anxiety; a preclinical and clinical review. Eur Neuropsychopharmacol 10 (2000) 77-95
28. Paulmier C. Selenoorganic functional groups. In: Paulmier C. (Ed). Selenium reagents and intermediates in organic synthesis. first ed. (1986), Oxford, Pergamon Press, Oxford 25-51
29. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
30. Prigol M., Wilhelm E.A., Schneider C.C., and Nogueira C.W. Protective effect of unsymmetrical dichalcogenide, a novel antioxidant agent, in vitro and an in vivo model of brain oxidative damage. Chem-Biol Interact 176 (2008) 129-136
31. Prigol M., Luchese C., and Nogueira C.W. Antioxidant effect of diphenyl diselenide on oxidative stress caused by acute physical exercise in skeletal muscle and lungs of mice. Cell Biochem Funct 27 (2009) 216-222
32. Prigol M., Brüning C.A., Zeni G., and Nogueira C.W. Protective Effect of Disubstituted Diaryl Diselenides on Cerebral Oxidative Damage Caused by Sodium Nitroprusside. Biochem Eng J 45 (2009) 94-99
33. Prigol M., Schumacher R.F., Nogueira C.W., and Zeni G. Convulsant effect of diphenyl diselenide in rats and mice and its relationship to plasma levels. Toxicol Lett 189 (2009) 35-39
34. Rault S., Lancelot J.C., Prunier H., Robba M., Renard P., Delagrange P., Pfeiffer B., Caignard D.H., Guardiola-Lemaitre B., and Hamonr M. Novel Selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines. J Med Chem 39 (1996) 2068-2080
35. Rayman M.P. The importance of selenium to human health. Lancet 356 (2000) 233-241
36. Rosa R.M., Roesler R., Braga A.L., Saffi J., and Henriques J.A.P. Pharmacology and toxicology of diphenyl diselenide in several biological models. Braz J Med Biol Res 40 (2007) 1287-1304
37. Savegnago L., Pinto L.G., Jesse C.R., Alves D., Rocha J.B.T., Nogueira C.W., and Zeni G. Antinociceptive properties of diphenyl diselenide: evidences for the mechanism of action. Eur J Pharmacol 555 (2007) 129-138
38. Savegnago L., Jesse C.R., Pinto L.G., Rocha J.B.T., Barancelli D.A., Nogueira C.W., and Zeni G. Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: Involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressant-like action. Pharmacol Biochem Behav 88 (2008) 418-426
39. Savegnago L., Jesse C.R., and Nogueira C.W. Structural modifications into diphenyl diselenide molecule do not cause toxicity in mice. Environ Toxicol Pharmacol 27 (2009) 271-276
40. Sonavane G.S., Sarveiya1 V.P., Kasture V.S., and Kasture S.B. Anxiogenic activity of Myristica fragrans seeds. Pharmacol Biochem Behav 71 (2002) 239-244
41. Soares V.P., and Zangrossi Jr. H. Stimulation of 5-HT1A or 5-HT2A receptors in the ventrolateral periaqueductal gray causes anxiolytic-, but not panicolytic-like effect in rats. Behav Brain Res 197 (2009) 178-185
42. Soto-Otero R., Mendez-Alvarez E., Hermida-Ameijeiras A., Sanchez-Sellero I., Cruz-Landeira A., and Lamas M.L. Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress. Life Sci 69 (2001) 879-889
43. Sprouse J.S., and Aghajanian G.K. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1 (1987) 3-9
44. Ursini F., and Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids 44 (1987) 255-276
45. Vasar E., Peuranen E., Oopick T., Harro J., and Mannisto P.T. Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze. Psychopharmacology 110 (1993) 213-218
46. Weis S.N., Favero A.M., Stangherlin E.C., Manarin F.G., Rocha J.B.T., Nogueira C.W., and Zeni G. Repeated administration of diphenyl diselenide to pregnant rats induces adverse effects on embryonic/fetal development. Reprod Toxicol 23 (2006) 175-181
47. Wong M., and Licinio J. Research and treatment approaches to depression. Nat Ver Neurosci 2 (2001) 343-351
48. Walsh R.N., and Cummins R.A. The open-field test: a critical review. Psychol Bull 83 (1976) 482-504
49. Yamada M., and Yasuhara H. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 25 (2004) 215-221
50. Zohar J., and Westenberg H.G. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 403 (2000) 39-49